- $4.19m
- $2.08m
- $19.19m
Brief: cbdMD Announces Strategic Acquisition of Bluebird Botanicals
Brief: Cbdmd Reports Preliminary Unaudited Fourth Quarter Results
Brief: CbdMD Inc - Effective Sep 30, Enters Securities Purchase Agreements With Four Investors - SEC Filing
Brief: CbdMD Inc - Reduces Principal On Senior Secured Convertible Notes To $56,000
Brief: cbdMD Inc Announces Notification Of Noncompliance With Additional NYSE American Continued Listing Standard
Brief: Cbdmd Inc Suspends Monthly Dividend Payment On Its Series A Cumulative Convertible Preferred Stock
Brief: Cbdmd - Entered Into Underwriting Agreement Relating To Issuance, Sale Of 1.35 Mln Shares
Brief: Cbdmd Inc Files For Sale Of Up To 13.1 Million Shares Of Common Stock By The Selling Stockholder - SEC Filing
Brief: Cbdmd Inc - On March 2, 2023 Co And Keystone Entered Into A Common Stock Purchase Agreement
Brief: CBDMD Inc - Effective June 22, Co Entered Into Membership Interest Transfer Agreement With Blystone & Donaldson, Llc., And Thomas Finke
Brief: cbdMD Inc Says Scott G. Stephen Assumed Position Of Chairman Of Board
CbdMD falls after SEC accuses CEO of fraud
AMEX RESUMED CBDMD INC
AMEX HALT NEWS PENDING LAST 0.690100
Brief: cbdMD Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing
Brief: cbdMD Expands Product Offering And Nationwide Footprint With Major Retail Partner GNC
Brief: cbdMD Inc Reports FY Loss Per Share $0.47
Brief: cbdMD Therapeutics Announces Human Clinical Study In Collaboration With The University Of South Carolina
cbdMD jumps on Amify tie-up to include CBD products on Amazon Marketplace